Alzamend Neuro Inc (ALZN) — Cash Flow-to-Debt Ratio
Latest as of April 2026:
-2.08x
Alzamend Neuro Inc (ALZN) has a Cash Flow-to-Debt Ratio of -2.08x as of April 2026, meaning its operating cash flow of $-2.80 Million could theoretically repay -2% of its total liabilities ($1.35 Million) in one year. See how financially flexible is Alzamend Neuro Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-2.08x
Operating CF / Total Liabilities
Operating Cash Flow
$-2.80 Million
USD
Total Liabilities
$1.35 Million
USD
Data as of
Apr 2026
Most recent filing
Alzamend Neuro Inc Cash Flow-to-Debt Ratio (2016–2026)
Historical debt coverage capacity for Alzamend Neuro Inc across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Alzamend Neuro Inc.
Annual Cash Flow-to-Debt Ratio for Alzamend Neuro Inc (2016–2026)
Year-by-year debt coverage analysis for Alzamend Neuro Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -5.99x | $-8.07 Million | $1.35 Million | ▲ +42.1% |
| 2025 | -10.35x | $-6.57 Million | $634.76K | ▼ -303.6% |
| 2024 | -2.56x | $-8.27 Million | $3.23 Million | ▲ +17.5% |
| 2023 | -3.11x | $-8.92 Million | $2.87 Million | ▲ +45.2% |
| 2022 | -5.68x | $-6.61 Million | $1.16 Million | ▼ -88.3% |
| 2021 | -3.01x | $-2.71 Million | $899.64K | ▼ -27.5% |
| 2020 | -2.36x | $-2.35 Million | $992.31K | ▼ -167.8% |
| 2019 | -0.88x | $-1.05 Million | $1.18 Million | ▲ +95.8% |
| 2018 | -21.21x | $-2.05 Million | $96.72K | ▼ -973.9% |
| 2017 | -1.98x | $-1.42 Million | $717.22K | ▼ -228.1% |
| 2016 | -0.60x | $-18.49K | $30.72K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.